Resistance to Targeted ABC Transporters in Cancer
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Edición: | 1st ed. 2015. |
| Colección: | Resistance to Targeted Anti-Cancer Therapeutics,
4 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-319-09801-2 |
Tabla de Contenidos:
- Role of P-glycoprotein for resistance of tumors to anticancer drugs: From bench to bedside
- Clinical relevance of multidrug-resistance-related proteins (MRPs) for anticancer drug resistance and prognosis
- Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance
- A new strategy of ALA-photodynamic cancer therapy: Inhibition of ABC transporter ABCG2
- ABC transporters in cancer stem-like cells
- Radiopharmaceuticals for the imaging of ABC-transporter-mediated multidrug resistance in cancer
- Modulation of P-glycoprotein-mediated multidrug resistance by synthetic and phytochemical small molecules, monoclonal antibodies and therapeutic nucleic acids
- ABC transporter modulatory drugs from marine sources: A new approach to overcome drug resistance in cancer
- The role of ABC multidrug transporters in resistance to targeted anti-cancer kinase inhibitors
- Nanotechnology to combat multidrug resistance in cancer
- Drugs affecting epigenetic modifications of ABC transporters.